AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3
slide-4

Telni-M Tablet SR

Prescription Icon
Prescription Required

Marketer

Elder Laboratories Limited

Salt Composition

Metformin (500mg) + Teneligliptin (20mg)

Overview Telni-M Tablet SR

Diabetease-Duo SR tablets combine two active ingredients to manage elevated blood glucose in individuals with type 2 diabetes. This dual action helps mitigate serious diabetic complications like nephropathy and vision impairment, and may lessen the risk of cardiovascular events. Diabetease-Duo SR may be prescribed as monotherapy or in conjunction with other antidiabetic agents. Optimal efficacy is achieved with a balanced diet and regular physical activity. Dosage is individualized based on your health status, glucose levels, and existing medications. Ingesting it with food minimizes gastrointestinal discomfort. Consistent daily dosing at the same time maximizes therapeutic benefit; discontinuation should only occur under medical supervision. Effective blood sugar control helps prevent long-term complications. Adherence to your physician's dietary and exercise plan is crucial. Lifestyle modifications significantly impact diabetes management. Commonly reported side effects include nausea, vomiting, diarrhea, abdominal discomfort, and headache. Hypoglycemia is a potential adverse effect, particularly when used with insulin or sulfonylureas; learn how to identify and manage this. This medication is not universally suitable. Inform your doctor about pre-existing kidney, liver, or heart conditions, pancreatic issues, or excessive alcohol consumption before commencing treatment. Pregnant or lactating women should seek medical advice prior to use. Interaction with other medications is possible; disclose all current medications to ensure safety. Alcohol should be minimized due to its hypoglycemic effects. Your doctor will monitor your renal function and glucose levels throughout treatment.

Uses of Telni-M Tablet SR

Managing type 2 diabetes

Major Benefits of Telni-M Tablet SR:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the Telni-M SR tablet whole; avoid chewing, crushing, or fracturing it. It should be taken with a meal.

Common Side effects of Telni-M Tablet SR:

  • Nausea
  • Vomiting
  • Headache
  • Hypoglycemia (low blood glucose level)
  • Diarrhea

How to use Telni-M Tablet SR:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the Telni-M Tablet SR whole; avoid chewing, crushing, or fracturing it. It should be taken with food.

How Telni-M Tablet SR works:

Telni-M Extended-Release Tablets contain a dual-action antidiabetic formula.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Telni-M Tablet SR and alcohol is not advisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Telni-M Tablet SR during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescription. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Telni-M tablets are likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCONSULT YOUR DOCTOR

Driving ability while taking Telni-M Tablet SR is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Telni-M Tablet SR, potentially requiring dosage modification. Severe kidney disease contraindicates its use. Physician consultation is essential. Routine monitoring of kidney function is recommended during treatment.

LiverLiverUNSAFE

Patients with liver impairment should not take Telni-M Tablet SR due to potential safety concerns. A physician's consultation is recommended.

What if you forget to take Telni-M Tablet SR :

Should you forget a Telni-M Tablet SR dose, take it promptly. However, if your next dose is imminent, omit the missed one and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Telni-M Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Treatment

FAQs on Telni-M Tablet SR

Telni-M Tablet SR is safe when taken as prescribed. However, even with correct dosage, side effects such as nausea, diarrhea, vomiting, stomach upset, headache, nasal congestion, sore throat, respiratory infection, and hypoglycemia (low blood sugar) may occur. Hypoglycemia is more likely if you're also using insulin or sulfonylurea. Report any persistent issues to your doctor.
Telni-M Tablet SR typically doesn't cause low blood sugar (hypoglycemia). However, hypoglycemia can happen if you don't consume enough calories while using it. Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness. These are more likely if you skip meals, drink alcohol, overexert yourself, or take other diabetes medication with Telni-M. Regular blood sugar monitoring is therefore crucial. Always keep glucose tablets, honey, or fruit juice on hand.
Telni-M Tablet SR may cause nausea and vomiting. If vomiting occurs, sip small amounts of water or other fluids frequently. Persistent vomiting or signs of dehydration (dark, strong-smelling urine, infrequent urination) require immediate medical attention. Do not take other medications without your doctor's approval.
Telni-M Tablet SR is contraindicated in patients allergic to any of its components or excipients. It should also be avoided in those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Yes, Telni-M Tablet SR can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a rare but serious side effect resulting from excess lactic acid in the bloodstream. To minimize risk, it's avoided in patients with kidney disease, older adults, and heavy alcohol users. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, discontinue Telni-M Tablet SR and seek immediate medical attention.
Prolonged use of Telni-M Tablet SR can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and balance difficulties (ataxia). If you experience any of these symptoms, consult your doctor for vitamin B12 level monitoring and potential supplementation.
Store this medication in its original, tightly closed container, as directed on the label. Dispose of any unused medication safely and keep it out of reach of children, pets, and others.
Telni-M Tablet SR
125
MRP 145
13% off